The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection-study protocol for a two-stage randomised phase II trial. (2022)

First Author: Lee MJ
Attributed to:  MICA: RIVER - Recent HIV Infection Viral Eradication Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-022-06151-w

PubMed Identifier: 35382844

Publication URI: http://europepmc.org/abstract/MED/35382844

Type: Journal Article/Review

Volume: 23

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215